Amicus Therapeutics Inc
Biotechnology
Healthcare
FOLD
308 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.52
52 week high
12.01
high
8.68
52 week low
0.00
previous Close
8.57
P/E ratio
market cap
2.15 B
div yield
0
net incoming
-24.42 M
-12.61 %
net profit margin
-15.79 %
1.00 %
operating incoming
-9.47 M
-19.14 %
net change in cash
-22.72 M
28.97 %
cash on hand
159 M
-12.64 %
cost of revenue
15.22 M
30.08 %
top